 | • レポートコード：MRC2312MG11147 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、73ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学＆材料 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のミルベマイシンオキシム原薬市場規模と予測を収録しています。・世界のミルベマイシンオキシム原薬市場：売上、2018年-2023年、2024年-2029年 ・世界のミルベマイシンオキシム原薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のミルベマイシンオキシム原薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「純度98％」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ミルベマイシンオキシム原薬のグローバル主要企業は、Livzon Pharmaceutical Group Inc、 Zhejiang Hisun Pharmaceutical Co., Ltd、 Hubei Honch Pharmaceutical Co.,Ltd、 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTDなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ミルベマイシンオキシム原薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のミルベマイシンオキシム原薬市場：タイプ別、2018年-2023年、2024年-2029年 世界のミルベマイシンオキシム原薬市場：タイプ別市場シェア、2022年 ・純度98％、純度98％以上 世界のミルベマイシンオキシム原薬市場：用途別、2018年-2023年、2024年-2029年 世界のミルベマイシンオキシム原薬市場：用途別市場シェア、2022年 ・犬、猫、その他 世界のミルベマイシンオキシム原薬市場：地域・国別、2018年-2023年、2024年-2029年 世界のミルベマイシンオキシム原薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるミルベマイシンオキシム原薬のグローバル売上、2018年-2023年 ・主要企業におけるミルベマイシンオキシム原薬のグローバル売上シェア、2022年 ・主要企業におけるミルベマイシンオキシム原薬のグローバル販売量、2018年-2023年 ・主要企業におけるミルベマイシンオキシム原薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Livzon Pharmaceutical Group Inc、 Zhejiang Hisun Pharmaceutical Co., Ltd、 Hubei Honch Pharmaceutical Co.,Ltd、 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD ************************************************************* ・調査・分析レポートの概要 ミルベマイシンオキシム原薬市場の定義 市場セグメント 世界のミルベマイシンオキシム原薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のミルベマイシンオキシム原薬市場規模 世界のミルベマイシンオキシム原薬市場規模：2022年 VS 2029年 世界のミルベマイシンオキシム原薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのミルベマイシンオキシム原薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のミルベマイシンオキシム原薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：純度98％、純度98％以上 ミルベマイシンオキシム原薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：犬、猫、その他 ミルベマイシンオキシム原薬の用途別グローバル売上・予測 ・地域別市場分析 地域別ミルベマイシンオキシム原薬市場規模 2022年と2029年 地域別ミルベマイシンオキシム原薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Livzon Pharmaceutical Group Inc、 Zhejiang Hisun Pharmaceutical Co., Ltd、 Hubei Honch Pharmaceutical Co.,Ltd、 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD ... |
This research report provides a comprehensive analysis of the Milbemycin Oxime API market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Milbemycin Oxime API market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Milbemycin Oxime API, challenges faced by the industry, and potential opportunities for market players.
The global Milbemycin Oxime API market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Milbemycin Oxime API market presents opportunities for various stakeholders, including Dog, Cat. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Milbemycin Oxime API market. Additionally, the growing consumer demand present avenues for market expansion.
The global Milbemycin Oxime API market was valued at US$ 173.3 million in 2022 and is projected to reach US$ 292.1 million by 2029, at a CAGR of 6.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.
Key Features:
The research report on the Milbemycin Oxime API market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Milbemycin Oxime API market.
Market Overview: The report provides a comprehensive overview of the Milbemycin Oxime API market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 98% Purity, Purity Greater than 98%), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Milbemycin Oxime API market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Milbemycin Oxime API market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Milbemycin Oxime API market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Milbemycin Oxime API market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Milbemycin Oxime API market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Milbemycin Oxime API market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Milbemycin Oxime API, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Milbemycin Oxime API market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Milbemycin Oxime API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
98% Purity
Purity Greater than 98%
Market segment by Application
Dog
Cat
Other
Global Milbemycin Oxime API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Livzon Pharmaceutical Group Inc
Zhejiang Hisun Pharmaceutical Co., Ltd
Hubei Honch Pharmaceutical Co.,Ltd
JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
Outline of Major Chapters:
Chapter 1: Introduces the definition of Milbemycin Oxime API, market overview.
Chapter 2: Global Milbemycin Oxime API market size in revenue and volume.
Chapter 3: Detailed analysis of Milbemycin Oxime API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Milbemycin Oxime API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Milbemycin Oxime API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Milbemycin Oxime API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Milbemycin Oxime API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Milbemycin Oxime API Overall Market Size
2.1 Global Milbemycin Oxime API Market Size: 2022 VS 2029
2.2 Global Milbemycin Oxime API Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Milbemycin Oxime API Sales: 2018-2029
3 Company Landscape
3.1 Top Milbemycin Oxime API Players in Global Market
3.2 Top Global Milbemycin Oxime API Companies Ranked by Revenue
3.3 Global Milbemycin Oxime API Revenue by Companies
3.4 Global Milbemycin Oxime API Sales by Companies
3.5 Global Milbemycin Oxime API Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Milbemycin Oxime API Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Milbemycin Oxime API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Milbemycin Oxime API Players in Global Market
3.8.1 List of Global Tier 1 Milbemycin Oxime API Companies
3.8.2 List of Global Tier 2 and Tier 3 Milbemycin Oxime API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Milbemycin Oxime API Market Size Markets, 2022 & 2029
4.1.2 98% Purity
4.1.3 Purity Greater than 98%
4.2 By Type – Global Milbemycin Oxime API Revenue & Forecasts
4.2.1 By Type – Global Milbemycin Oxime API Revenue, 2018-2023
4.2.2 By Type – Global Milbemycin Oxime API Revenue, 2024-2029
4.2.3 By Type – Global Milbemycin Oxime API Revenue Market Share, 2018-2029
4.3 By Type – Global Milbemycin Oxime API Sales & Forecasts
4.3.1 By Type – Global Milbemycin Oxime API Sales, 2018-2023
4.3.2 By Type – Global Milbemycin Oxime API Sales, 2024-2029
4.3.3 By Type – Global Milbemycin Oxime API Sales Market Share, 2018-2029
4.4 By Type – Global Milbemycin Oxime API Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Milbemycin Oxime API Market Size, 2022 & 2029
5.1.2 Dog
5.1.3 Cat
5.1.4 Other
5.2 By Application – Global Milbemycin Oxime API Revenue & Forecasts
5.2.1 By Application – Global Milbemycin Oxime API Revenue, 2018-2023
5.2.2 By Application – Global Milbemycin Oxime API Revenue, 2024-2029
5.2.3 By Application – Global Milbemycin Oxime API Revenue Market Share, 2018-2029
5.3 By Application – Global Milbemycin Oxime API Sales & Forecasts
5.3.1 By Application – Global Milbemycin Oxime API Sales, 2018-2023
5.3.2 By Application – Global Milbemycin Oxime API Sales, 2024-2029
5.3.3 By Application – Global Milbemycin Oxime API Sales Market Share, 2018-2029
5.4 By Application – Global Milbemycin Oxime API Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Milbemycin Oxime API Market Size, 2022 & 2029
6.2 By Region – Global Milbemycin Oxime API Revenue & Forecasts
6.2.1 By Region – Global Milbemycin Oxime API Revenue, 2018-2023
6.2.2 By Region – Global Milbemycin Oxime API Revenue, 2024-2029
6.2.3 By Region – Global Milbemycin Oxime API Revenue Market Share, 2018-2029
6.3 By Region – Global Milbemycin Oxime API Sales & Forecasts
6.3.1 By Region – Global Milbemycin Oxime API Sales, 2018-2023
6.3.2 By Region – Global Milbemycin Oxime API Sales, 2024-2029
6.3.3 By Region – Global Milbemycin Oxime API Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Milbemycin Oxime API Revenue, 2018-2029
6.4.2 By Country – North America Milbemycin Oxime API Sales, 2018-2029
6.4.3 US Milbemycin Oxime API Market Size, 2018-2029
6.4.4 Canada Milbemycin Oxime API Market Size, 2018-2029
6.4.5 Mexico Milbemycin Oxime API Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Milbemycin Oxime API Revenue, 2018-2029
6.5.2 By Country – Europe Milbemycin Oxime API Sales, 2018-2029
6.5.3 Germany Milbemycin Oxime API Market Size, 2018-2029
6.5.4 France Milbemycin Oxime API Market Size, 2018-2029
6.5.5 U.K. Milbemycin Oxime API Market Size, 2018-2029
6.5.6 Italy Milbemycin Oxime API Market Size, 2018-2029
6.5.7 Russia Milbemycin Oxime API Market Size, 2018-2029
6.5.8 Nordic Countries Milbemycin Oxime API Market Size, 2018-2029
6.5.9 Benelux Milbemycin Oxime API Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Milbemycin Oxime API Revenue, 2018-2029
6.6.2 By Region – Asia Milbemycin Oxime API Sales, 2018-2029
6.6.3 China Milbemycin Oxime API Market Size, 2018-2029
6.6.4 Japan Milbemycin Oxime API Market Size, 2018-2029
6.6.5 South Korea Milbemycin Oxime API Market Size, 2018-2029
6.6.6 Southeast Asia Milbemycin Oxime API Market Size, 2018-2029
6.6.7 India Milbemycin Oxime API Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Milbemycin Oxime API Revenue, 2018-2029
6.7.2 By Country – South America Milbemycin Oxime API Sales, 2018-2029
6.7.3 Brazil Milbemycin Oxime API Market Size, 2018-2029
6.7.4 Argentina Milbemycin Oxime API Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Milbemycin Oxime API Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Milbemycin Oxime API Sales, 2018-2029
6.8.3 Turkey Milbemycin Oxime API Market Size, 2018-2029
6.8.4 Israel Milbemycin Oxime API Market Size, 2018-2029
6.8.5 Saudi Arabia Milbemycin Oxime API Market Size, 2018-2029
6.8.6 UAE Milbemycin Oxime API Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Livzon Pharmaceutical Group Inc
7.1.1 Livzon Pharmaceutical Group Inc Company Summary
7.1.2 Livzon Pharmaceutical Group Inc Business Overview
7.1.3 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Major Product Offerings
7.1.4 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Sales and Revenue in Global (2018-2023)
7.1.5 Livzon Pharmaceutical Group Inc Key News & Latest Developments
7.2 Zhejiang Hisun Pharmaceutical Co., Ltd
7.2.1 Zhejiang Hisun Pharmaceutical Co., Ltd Company Summary
7.2.2 Zhejiang Hisun Pharmaceutical Co., Ltd Business Overview
7.2.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Major Product Offerings
7.2.4 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Sales and Revenue in Global (2018-2023)
7.2.5 Zhejiang Hisun Pharmaceutical Co., Ltd Key News & Latest Developments
7.3 Hubei Honch Pharmaceutical Co.,Ltd
7.3.1 Hubei Honch Pharmaceutical Co.,Ltd Company Summary
7.3.2 Hubei Honch Pharmaceutical Co.,Ltd Business Overview
7.3.3 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Major Product Offerings
7.3.4 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Sales and Revenue in Global (2018-2023)
7.3.5 Hubei Honch Pharmaceutical Co.,Ltd Key News & Latest Developments
7.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
7.4.1 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Company Summary
7.4.2 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Business Overview
7.4.3 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Major Product Offerings
7.4.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Sales and Revenue in Global (2018-2023)
7.4.5 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Key News & Latest Developments
8 Global Milbemycin Oxime API Production Capacity, Analysis
8.1 Global Milbemycin Oxime API Production Capacity, 2018-2029
8.2 Milbemycin Oxime API Production Capacity of Key Manufacturers in Global Market
8.3 Global Milbemycin Oxime API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Milbemycin Oxime API Supply Chain Analysis
10.1 Milbemycin Oxime API Industry Value Chain
10.2 Milbemycin Oxime API Upstream Market
10.3 Milbemycin Oxime API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Milbemycin Oxime API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer